is the generic ingredient in two branded drugs marketed by Akorn Inc
, Mylan Institutional
, Par Sterile Products
, and Hospira
, and is included in four NDAs. There are five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.
There are twelve drug master file entries
for dexmedetomidine hydrochloride. Two suppliers
are listed for this compound. There are two tentative approvals for this compound.